Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Neuroradiology: Page 71
Who should get brain scans for Alzheimer's disease?
By
AuntMinnie.com staff writers
The growing utility of medical imaging technologies for detecting early signs of Alzheimer's disease is raising a conundrum for senior citizens: Should they actually get the scans?
August 4, 2019
Brain abnormalities on CT, MRI indicate severe Zika
By
Abraham Kim
Structural abnormalities visible on the brain MRI and CT scans of infants with the Zika virus had a significant association with severe clinical outcomes, especially in those initially affected by the virus during the first trimester of pregnancy, according to a study published online July 31 in
JAMA Network Open
.
July 31, 2019
MRA screening finds aneurysms related to kidney disease
By
Wayne Forrest
Can MR angiography (MRA) be effective in screening for brain aneurysms among patients with autosomal dominant polycystic kidney disease? A new study published online July 30 in the
Clinical Journal of the American Society of Nephrology
backs the modality, even when no symptoms are present.
July 30, 2019
UC Berkeley wins Alzheimer's brain imaging grant
By
AuntMinnie.com staff writers
The University of California, Berkeley (UC Berkeley) has been awarded a five-year, $47Â million grant from the U.S. National Institutes of Health's National Institute on Aging to incorporate brain imaging into a new, large clinical trial led by the Alzheimer's Association.
July 29, 2019
PET model tracks beta amyloid, Alzheimer's risk
By
Wayne Forrest
Swedish and Canadian researchers have developed a four-stage model that uses florbetapir-PET scans for tracking beta-amyloid accumulation in adults to gauge their risk of progression to Alzheimer's disease, according to a study published online July 17 in
JAMA Neurology
.
July 18, 2019
Imaging Biometrics points to brain tumor study
By
AuntMinnie.com staff writers
Advanced visualization software developer Imaging Biometrics is touting a recent study that evaluated the performance of its Delta T1 automated quantitative mapping software in assessing brain tumor burden.
July 17, 2019
AI can diagnose Alzheimer's from imaging, test scores
By
Erik L. Ridley
An artificial intelligence (AI) model that simulates a clinician's diagnostic process by analyzing both neuroimaging results and clinical cognitive impairment test scores can yield excellent performance for diagnosing Alzheimer's disease, according to research published online July 16 in
Neurocomputing
.
July 17, 2019
PET shows how women are more susceptible to Alzheimer's
By
Wayne Forrest
PET images have uncovered consistently greater accumulation of tau protein in the brains of women compared with men, bolstering the current knowledge on how one's sex might affect a progression to dementia, according to a study presented at this week's Alzheimer's Association International Conference.
July 17, 2019
PET, MRI show physical activity aids brain health
By
Wayne Forrest
PET and MR images show that older adults who are physically active have significantly less beta-amyloid accumulation and gray matter volume loss, which results in more stable cognitive skills, according to a study published online July 16 in
JAMA Neurology
.
July 16, 2019
Portable scanner could boost point-of-care brain MRI
By
Wayne Forrest
The ability to perform a whole-brain MRI scan at the point of care for patients with mobility challenges could soon become a reality with a portable, lightweight device now under development by researchers at the Massachusetts Institute of Technology in Cambridge, MA.
July 16, 2019
FDA clears Insightec's Exablate for GE's Signa MR scanner
By
AuntMinnie.com staff writers
MR-guided focused ultrasound developer Insightec has received clearance from the U.S. Food and Drug Administration (FDA), as well as the European CE Mark, for use of its Exablate Neuro device with GE Healthcare's Signa Premier MRI system.
July 10, 2019
GBCA-enhanced MRI does not influence MS progression
By
Wayne Forrest
Researchers found evidence of gadolinium accumulation in the brains of multiple sclerosis (MS) patients after MRI scans using a gadolinium-based contrast agent (GBCA), but the patients' conditions did not worsen by the five-year follow-up in a new study, published online July 5 in
Neurology
.
July 10, 2019
Previous Page
Page 71 of 238
Next Page